Lisata Therapeutics Named 'Specialized BioTherapeutics Company of the Year' at 2024 BioTech Breakthrough Awards
Lisata Therapeutics receives the ‘Specialized BioTherapeutics Company of the Year’ award for innovative cancer therapies and clinical advancements.Quiver AI SummaryLisata Therapeutics, Inc., a clinical-stage...
Esperion's Q3 Loss Wider Than Expected, Revenues Rise Y/Y
Esperion Therapeutics, Inc. ESPR incurred a loss of 15 cents per share for the third quarter of 2024, which was wider than the Zacks Consensus Estimate of a loss of 14 cents. The company had incurred a...
Impilo Therapeutics Launches to Enable Nucleic Acid-Based Medicines to Effectively Treat Solid Tumor Cancers
/PRNewswire/ -- Impilo Therapeutics, Inc. ("Impilo"), a privately held drug discovery and development company, today announced that it has launched with the...